Riskpilot← Back to searchSign inGet full accessMedsbag AB
ABActiveOrg 5592961063Katarina Bangata 13Other non-specialised retail sale · NACE 4712Est. 20210 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Medsbag AB
Org number
5592961063
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
12 januari 2021
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget är ett patientinitiativ som verkar för att höja status och säkerheten för barn och ungdomar med allergi, astma, diabetes och epilepsi, det vill säga de närmare 500 miljoner vardagshjältar som bär med sig livsviktig medicin i vardagen. Företaget utvecklar och marknadsför en standardiserad symbolväska, som genom bl.a. synbarhet och den audiobaserade handlingsplanen inkluderar alla barn och unga som bär med sig mediciner genom skolvardagens samtliga aktiviteter.
Address
Katarina Bangata 13
Email
rebeccabyronlohk@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 169 | 1 | — |
| Staff expenses | — | −207 | −0 | — |
| EBITDA | −1 083 | −378 | −96 | 0 |
| Depreciation & amort. | −0 | — | −3 | — |
| EBIT | −1 083 | −378 | −99 | 0 |
| Net financials | — | −0 | −0 | — |
| Profit before tax | −1 083 | −378 | −99 | 0 |
| Tax | −0 | — | — | — |
| Net profit | −1 083 | −378 | −99 | — |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 167 | 193 | 122 | — |
| Equity | 167 | −224 | 50 | — |
| Long-term debt | 0 | 400 | 0 | — |
| Short-term debt | 0 | 18 | 71 | — |
| Total debt | — | 418 | 71 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HI Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BBEX Company AB
Medsbag AB Board members of Medsbag AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hannah Isabella Lohk | Chief Executive Officer | 0 companies |
| Oliver Byron Lohk | Deputy Board Member | 0 companies |
| Jan Henrik Lohk | Deputy Board Member | 0 companies |
| Nina Rebecca Lohk | Chairman | 0 companies |